Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 17, 2018 - Issue 5
Submit an article Journal homepage
1,525
Views
12
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia

Bertram PittInternal Medicine, Department of Medicine, Cardiovascular Center, University of Michigan School of Medicine, Ann Arbor, MI, USACorrespondence[email protected]
View further author information
&
Dahlia GarzaMedical affairs, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USAView further author information
Pages 525-535 | Received 06 Feb 2018, Accepted 04 Apr 2018, Published online: 22 Apr 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gates Colbert, Shilpa Sannapaneni & Edgar V Lerma. (2022) Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia. Drug, Healthcare and Patient Safety 14, pages 87-96.
Read now

Articles from other publishers (11)

Juan Jesus Carrero, Manish M Sood, Ailema Gonzalez-Ortiz & Catherine M Clase. (2023) Pharmacological strategies to manage hyperkalaemia: out with the old, in with the new? Not so fast…. Clinical Kidney Journal 16:8, pages 1213-1220.
Crossref
Lingqiu Dong, Weidong Xu, Yi Deng, Jiaxing Tan & Wei Qin. (2022) Efficacy and safety of potassium binders in the treatment of patients with chronic kidney disease and hyperkalemia. European Journal of Pharmacology 931, pages 175174.
Crossref
Alberto Esteban‐Fernández, Carolina Ortiz Cortés, Silvia López‐Fernández, Alejandro Recio Mayoral, Francisco Javier Camacho Jurado, Inés Gómez Otero, María Molina, Luis Almenar Bonet & Raquel López‐Vilella. (2022) Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life. ESC Heart Failure.
Crossref
Wiktoria Baran, Julia Krzemińska, Magdalena Szlagor, Magdalena Wronka, Ewelina Młynarska, Beata Franczyk & Jacek Rysz. (2021) Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease. International Journal of Molecular Sciences 22:18, pages 9995.
Crossref
Enrique Morales, Paolo Cravedi & Joaquin Manrique. (2021) Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options. Frontiers in Medicine 8.
Crossref
Waleed Ali & George Bakris. (2020) Evolution of Patiromer Use: a Review. Current Cardiology Reports 22:9.
Crossref
Pasquale Esposito, Novella Evelina Conti, Valeria Falqui, Leda Cipriani, Daniela Picciotto, Francesca Costigliolo, Giacomo Garibotto, Michela Saio & Francesca Viazzi. (2020) New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease. Journal of Clinical Medicine 9:8, pages 2337.
Crossref
Silvia J. Leon, Oksana Harasemiw & Navdeep Tangri. (2019) New therapies for hyperkalemia. Current Opinion in Nephrology and Hypertension 28:3, pages 238-244.
Crossref
Giuseppe M C Rosano, Ilaria Spoletini & Stefan Agewall. (2019) Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate. European Heart Journal Supplements 21:Supplement_A, pages A28-A33.
Crossref
Joshua P. Gray, Jeeseon Rosa Kim & Sidhartha D. Ray. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 237 249 .
Hannah A. Blair. (2018) Patiromer: A Review in Hyperkalaemia. Clinical Drug Investigation 38:8, pages 785-794.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.